
- This event has passed.
Embracing complexity in modern pathology
This event has now passed
This interactive webinar seeks to promote understanding and increased knowledge amongst pathologists and scientists on disease models, molecular technologies, and the integration of digital pathology in the training of the next generation of histopathologists.
Click here to view a quick guide on how to register.
The event will provide delegates with networking opportunities and they will also have the chance to review poster presentations a week prior to the webinar as well as after it has taken place.
Topics will focus on engineered disease models to provide deep insights into what knowledge can be gained and potentially transferred into the clinic from building complex tumour models considering the tumour microenvironment. Additionally, the symposium will be about special types of RNA and a detailed demonstration of fascinating molecular technologies that work on tissue sections will provide a unique view and eyeopener about advances in these two cutting edge fields.
The educational component of this webinar allows discussion of recent teaching developments using digital platforms and assessment of the pros and cons of integrating digital pathology in the training.
This webinar is jointly organised by the RSM Pathology Section and the Pathological Society of Great Britain and Ireland.
During this session, participants will be able to:
- Understand and know about recent developments in disease models
- Understand and know about recent developments in tissue section based (in situ) molecular technologies
- Evaluate innovative ways of teaching histopathology and other trainees
- Understand the pros and cons of integrating digital pathology in histopathology training
This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 60 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
Join in the conversation onlineFollow us on Twitter: @RoySocMed
